Trends in the management of atrial fibrillation: A neurologist's perspective

Vishnumurthy Shushrutha Hedna1, Christopher G Favilla, Waldo R Guerrero

  • 1Department of Vascular Neurology, University of Florida, Gainesville, USA.

Insights

Atrial fibrillation (AF) causes a quarter of ischemic strokes. This review explores new oral anticoagulants and surgical devices for stroke prevention in AF patients, offering a neurologist

Area of Science:

  • Neurology
  • Cardiology
  • Internal Medicine

Background:

  • Cardiac embolism from atrial fibrillation (AF) accounts for 25% of ischemic strokes.
  • Managing AF stroke risk presents challenges, especially with contraindications to traditional anticoagulants.
  • Evolving medical and surgical treatments offer new options for AF management.

Purpose of the Study:

  • To review current trends in atrial fibrillation management for stroke prevention.
  • To discuss newer oral anticoagulants and surgical devices for secondary stroke prophylaxis in AF patients.
  • To provide a neurologist's perspective on therapeutic choices.

Main Methods:

  • Review of current literature on atrial fibrillation management.
  • Analysis of newer oral anticoagulants (NOACs) and surgical interventions.
  • Focus on therapeutic strategies relevant to neurological outcomes.

Main Results:

  • A wide array of therapeutic options now exists for AF management.
  • Newer oral anticoagulants offer alternatives to traditional therapies.
  • Surgical devices provide additional avenues for stroke risk reduction in specific AF populations.

Conclusions:

  • Optimal management of AF for stroke prevention requires consideration of diverse therapeutic options.
  • Neurologists play a key role in guiding secondary stroke prophylaxis decisions in AF patients.
  • Emerging therapies enhance the ability to tailor treatment for individual patient needs and contraindications.

Related Concept Videos

Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Dysrhythmias VII: Nursing Management of Dysrhythmias01:25

Dysrhythmias VII: Nursing Management of Dysrhythmias

Nursing management of dysrhythmias involves the following:AssessmentSubjective Assessment:The initial step involves gathering patient-reported symptoms such as dizziness, palpitations, and chest discomfort. It is crucial to collect a detailed history, including previous heart conditions, current medication use, and lifestyle factors like caffeine and alcohol consumption.Objective Assessment:This involves observing clinical signs such as jugular venous distention, cool and pale skin, and...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...